G F Sawaya

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Frequency of cervical smear abnormalities within 3 years of normal cytology
    G F Sawaya
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143 0856, USA
    Obstet Gynecol 96:219-23. 2000
  2. ncbi request reprint Cervical neoplasia risk in women provided hormonal contraception without a Pap smear
    G F Sawaya
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA
    Contraception 63:57-60. 2001
  3. doi request reprint Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94118, USA
    Obstet Gynecol 112:990-7. 2008
  4. ncbi request reprint A 21-year-old woman with atypical squamous cells of undetermined significance
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
    JAMA 294:2210-8. 2005
  5. ncbi request reprint Outcomes associated with cesarean section versus vaginal breech delivery at a university hospital
    L M Hopkins
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143 0705, USA
    J Perinatol 27:141-6. 2007
  6. ncbi request reprint Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Fracisco, 3333 California Street, Suite 335, San Francisco, California 94143 0856, USA
    Acta Cytol 49:391-7. 2005
  7. ncbi request reprint Discontinuation of postmenopausal hormone therapy
    Deborah Grady
    Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
    Am J Med 118:163-5. 2005
  8. ncbi request reprint Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections
    Karen K Smith-McCune
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA 94143 0128, USA
    J Low Genit Tract Dis 10:213-8. 2006
  9. ncbi request reprint Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial
    Deborah Grady
    University of California, San Francisco, and San Francisco VA Medical Center, San Francisco, California 94115, USA
    Obstet Gynecol 109:823-30. 2007
  10. doi request reprint Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe
    Emily Fukuchi
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA
    Sex Transm Dis 36:305-11. 2009

Collaborators

Detail Information

Publications47

  1. ncbi request reprint Frequency of cervical smear abnormalities within 3 years of normal cytology
    G F Sawaya
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94143 0856, USA
    Obstet Gynecol 96:219-23. 2000
    ..To compare cervical screening outcomes associated with age and three screening intervals, 1, 2, and 3 years...
  2. ncbi request reprint Cervical neoplasia risk in women provided hormonal contraception without a Pap smear
    G F Sawaya
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA
    Contraception 63:57-60. 2001
    ..Future research should quantify more precisely the risks and benefits of the general application of this strategy on a population level...
  3. doi request reprint Effect of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms: a randomized controlled trial
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California 94118, USA
    Obstet Gynecol 112:990-7. 2008
    ..To estimate the effect of providing women with a latex diaphragm, lubricant gel, and male condoms (intervention) compared with condoms alone (control) on human papillomavirus (HPV) incidence and clearance...
  4. ncbi request reprint A 21-year-old woman with atypical squamous cells of undetermined significance
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
    JAMA 294:2210-8. 2005
  5. ncbi request reprint Outcomes associated with cesarean section versus vaginal breech delivery at a university hospital
    L M Hopkins
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143 0705, USA
    J Perinatol 27:141-6. 2007
    ..This study encompasses our previous studies (in 1987 and 1995) and extends our experience to 21 years...
  6. ncbi request reprint Cervical cancer after multiple negative cytologic tests in long-term members of a prepaid health plan
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Fracisco, 3333 California Street, Suite 335, San Francisco, California 94143 0856, USA
    Acta Cytol 49:391-7. 2005
    ..To estimate squamous cell cervical cancer incidence within 3.5 years of 1, 2 and > or = 3 consecutive, normal cytologic tests...
  7. ncbi request reprint Discontinuation of postmenopausal hormone therapy
    Deborah Grady
    Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, USA
    Am J Med 118:163-5. 2005
    ..For women who cannot tolerate even a slow taper, the value of symptom relief likely outweighs any increased risks due to HT use...
  8. ncbi request reprint Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections
    Karen K Smith-McCune
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, CA 94143 0128, USA
    J Low Genit Tract Dis 10:213-8. 2006
    ..We hypothesized that Replens gel used with a diaphragm would neither inhibit human papillomavirus (HPV) detection in cervical samples and chlamydia (CT) and gonorrhea (GC) detection in urine samples, nor affect cervical cytology quality...
  9. ncbi request reprint Ineffectiveness of sertraline for treatment of menopausal hot flushes: a randomized controlled trial
    Deborah Grady
    University of California, San Francisco, and San Francisco VA Medical Center, San Francisco, California 94115, USA
    Obstet Gynecol 109:823-30. 2007
    ..To estimate the effect of the selective serotonin reuptake inhibitor sertraline on hot flush frequency and severity in perimenopausal and postmenopausal women...
  10. doi request reprint Cervical human papillomavirus incidence and persistence in a cohort of HIV-negative women in Zimbabwe
    Emily Fukuchi
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA
    Sex Transm Dis 36:305-11. 2009
    ..Little is known about the distribution of HPV types, independent risk factors of incidence and persistence, and patterns of persistence in sub-Saharan Africa...
  11. doi request reprint MF101, a selective estrogen receptor beta modulator for the treatment of menopausal hot flushes: a phase II clinical trial
    Deborah Grady
    University of California, San Francisco, San Francisco, CA 94115, USA
    Menopause 16:458-65. 2009
    ..To determine the optimal dose, safety, and efficacy of an estrogen receptor beta selective Chinese herbal extract, menopausal formula 101 (MF101), for treating hot flushes...
  12. pmc Oophorectomy as a risk factor for coronary heart disease
    Vanessa L Jacoby
    Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA 94115, USA
    Am J Obstet Gynecol 200:140.e1-9. 2009
    ..The objective of the study was to examine the relationship between bilateral oophorectomy (BSO) and risk of coronary heart disease (CHD)...
  13. ncbi request reprint Cervical cancer screening continues to limit provision of contraception
    Eleanor Bimla Schwarz
    General Internal Medicine Section, Department of Medicine, University of California, San Francisco UCSF, San Francisco, CA 94121, USA
    Contraception 72:179-81. 2005
    ..We assessed US obstetrician/gynecologists' practices regarding requirement of Pap testing before prescribing oral contraceptive or emergency contraceptive pills...
  14. pmc Type-specific cervico-vaginal human papillomavirus infection increases risk of HIV acquisition independent of other sexually transmitted infections
    Karen K Smith-McCune
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, San Francisco, California, United States of America
    PLoS ONE 5:e10094. 2010
    ..The objective of this study was to determine whether cervico-vaginal HPV infection increases the risk of HIV acquisition in women independent of other common STIs...
  15. ncbi request reprint Changes in cervical cancer incidence after three decades of screening US women less than 30 years old
    Pamela G Chan
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, San Francisco, California 94122, USA
    Obstet Gynecol 102:765-73. 2003
    ..To examine incidence trends of invasive cervical carcinoma in US women less than 30 years old from 1973 to 1999 by histologic type...
  16. pmc Pelvic examinations and access to oral hormonal contraception
    Jillian T Henderson
    Department of Obstetrics, Gynecology and Reproductive Sciences, Bixby Center for Global Reproductive Health, University of California, San Francisco, San Francisco, California, USA
    Obstet Gynecol 116:1257-64. 2010
    ..Our purpose was to investigate clinicians' requirements for pelvic examination and what may account for practice differences...
  17. pmc Preferences for surveillance strategies for women treated for high-grade precancerous cervical lesions
    M Kuppermann
    Department of Obstetrics, Gynecology and Reproductive Sciences, Medical Effectiveness Research Center for Diverse Populations, University of California San Francisco, 3333 California Street, San Francisco, CA 94143, USA
    Gynecol Oncol 118:108-15. 2010
    ..We measured and compared patient preferences (utilities) for scenarios with varying surveillance strategies and outcomes to inform guidelines and cost-effectiveness analyses of post-treatment surveillance options...
  18. pmc Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women
    Alison J Huang
    Departments of Medicine, University of California, San Francisco, CA 94115, USA
    Menopause 16:639-43. 2009
    ..The aim of this study was to examine interactions between hot flushes, estrogen plus progestogen therapy (EPT), and coronary heart disease (CHD) events in postmenopausal women with CHD...
  19. pmc Impact of loop electrosurgical excision procedure for cervical intraepithelial neoplasia on HIV-1 genital shedding: a prospective cohort study
    M J Huchko
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California San Francisco, CA 94105, USA
    BJOG 120:1233-9. 2013
    ..We sought to examine the impact of the loop electrosurgical excision procedure (LEEP) on the rate and magnitude of HIV-1 genital shedding among women undergoing treatment for cervical intraepithelial neoplasia 2/3 (CIN2/3)...
  20. ncbi request reprint Advancing age and cervical cancer screening and prognosis
    G F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, 94143, USA
    J Am Geriatr Soc 49:1499-504. 2001
    ..30, 95% confidence interval 0.75-2.28). CONCLUSION: The disproportionate burden of cervical cancer observed in older women appears to be largely attributable to lack of screening within the 3 years before diagnosis...
  21. pmc Preferences for human papillomavirus testing with routine cervical cancer screening in diverse older women
    Alison J Huang
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA
    J Gen Intern Med 23:1324-9. 2008
    ..Little is known about women's attitudes toward HPV testing or how these attitudes may influence medical discussions about cervical cancer screening...
  22. ncbi request reprint Risk of cervical cancer associated with extending the interval between cervical-cancer screenings
    George F Sawaya
    Department of Obstetrics, Gynecology, and Reproductive Sciences, Department of Veterans Affairs and University of California, San Francisco, San Francisco, USA
    N Engl J Med 349:1501-9. 2003
    ....
  23. doi request reprint Surveillance after treatment for cervical intraepithelial neoplasia: outcomes, costs, and cost-effectiveness
    Joy Melnikow
    Department of Economics, Center for Healthcare Policy and Research, University of California, Davis, California 95817, USA
    Obstet Gynecol 116:1158-70. 2010
    ..To estimate outcomes and costs of surveillance strategies after treatment for high-grade cervical intraepithelial neoplasia (CIN)...
  24. ncbi request reprint Clinical breast and pelvic examination requirements for hormonal contraception: Current practice vs evidence
    F H Stewart
    Center for Reproductive Health Research and Policy, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, 3333 California St, Suite 335, San Francisco, CA 94143 0744, USA
    JAMA 285:2232-9. 2001
    ....
  25. ncbi request reprint Should routine screening Papanicolaou smears be done for women older than 65 years?
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, CA 94143, USA
    Arch Intern Med 164:243-5; discussion 247-8. 2004
  26. ncbi request reprint Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests
    Shalini L Kulasingam
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, USA
    Obstet Gynecol 107:321-8. 2006
    ..We estimated the cost-effectiveness of screening women with 3 or more prior normal tests compared with screening those with no prior tests...
  27. pmc Ending cervical cancer screening: attitudes and beliefs from ethnically diverse older women
    George F Sawaya
    Department of Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco, School of Medicine, San Francisco, CA, USA
    Am J Obstet Gynecol 200:40.e1-7. 2009
    ..Guidelines support ending cervical cancer screening in women aged 65-70 years and older with previous normal testing, but little is known about older women's attitudes and beliefs about ending screening...
  28. doi request reprint Association between cancer risk perception and screening behavior among diverse women
    Sue E Kim
    Department of Medicine, Medical Effectiveness Research Center for Diverse Populations, University of California, San Francisco, 400 Parnassus Ave, A 405, Box 0856, San Francisco, CA 94143 0856, USA
    Arch Intern Med 168:728-34. 2008
    ..We measured the perception of breast, cervical, and colon cancer risks and screening in diverse women to examine the association between risk perception and screening behavior...
  29. ncbi request reprint Screening interval and risk of invasive squamous cell cervical cancer
    Marie Grisham Miller
    Department of Quality and Utilization, Kaiser Permanente Medical Care Program, Oakland, California 94553, USA
    Obstet Gynecol 101:29-37. 2003
    ..Our findings need to be placed in the context of the low absolute risks of developing invasive cervical cancer during the first 3 years after a negative cervical smear before making policy recommendation...
  30. ncbi request reprint Testing for human papillomavirus in women with abnormal pap smear results
    George F Sawaya
    JAMA 288:1350-1; author reply 1351-2. 2002
  31. ncbi request reprint Stage at diagnosis and mortality in patients with adenocarcinoma and adenosquamous carcinoma of the uterine cervix diagnosed as a consequence of cytologic screening
    Walter Kinney
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Department of Quality and Utilization, and Division of Research, Kaiser Permanente Medical Care Program, Oakland, California, USA
    Acta Cytol 47:167-71. 2003
    ..To determine if cytologic screening is associated with early stage at diagnosis of and decreased mortality from invasive adenocarcinoma and adenosquamous carcinoma of the uterine cervix...
  32. ncbi request reprint Papanicolaou testing: when does more become less?
    George F Sawaya
    Am J Med 118:159-60. 2005
  33. doi request reprint Persistent hot flushes in older postmenopausal women
    Alison J Huang
    Department of Medicine, University of California San Francisco, USA
    Arch Intern Med 168:840-6. 2008
    ..To examine the prevalence, natural history, and predictors of hot flushes in older postmenopausal women...
  34. ncbi request reprint Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later
    George F Sawaya
    Ann Intern Med 148:557-9. 2008
  35. ncbi request reprint Cervical cancer screening among women without a cervix
    Mona Saraiya
    JAMA 292:1551; author reply 1551-2. 2004
  36. ncbi request reprint Current cervical neoplasia screening practices of obstetrician/gynecologists in the US
    Mona Saint
    Department of Obstetrics and Gynecology, Kaiser Permanente Northern California, USA
    Am J Obstet Gynecol 192:414-21. 2005
    ..The purpose of this study was to determine cervical cancer screening practices of obstetrician/gynecologists in the US after recent revised guidelines...
  37. ncbi request reprint HPV vaccination--more answers, more questions
    George F Sawaya
    N Engl J Med 356:1991-3. 2007
  38. ncbi request reprint Trials that matter: liquid-based cervical cytology: disadvantages seem to outweigh advantages
    George F Sawaya
    Ann Intern Med 147:668-9. 2007
  39. ncbi request reprint USPSTF recommendations for STI screening
    David Meyers
    U S Preventive Services Task Force, Agency for Healthcare Research and Quality Center for Primary Care, Prevention, and Clinical Partnerships, Rockville, Maryland 20850, USA
    Am Fam Physician 77:819-24. 2008
    ....
  40. doi request reprint Evidence-based medicine versus liquid-based cytology
    George F Sawaya
    Obstet Gynecol 111:2-3. 2008